The laboratory study was conducted by Pfizer and scientists from the University of Texas Medical Branch.
According to the study, which is yet to be peer-reviewed, the Covid-19 vaccine from Pfizer-BioNTech seems effective in neutralizing UK variant coronavirus, the report said.Covid-19 vaccine update: Here’s a piece of good news in the New Year. Even though the new Covid-19 virus strain from the UK is threatening new curbs across the world due to its higher transmission capabilities, Pfizer-BioNTech’s COVID-19 vaccine is found to be effective against the UK variant coronavirus, according to a study.
The laboratory study was conducted by Pfizer and scientists from the University of Texas Medical Branch. According to the study, which is yet to be peer-reviewed, the Covid-19 vaccine from Pfizer-BioNTech seems effective in neutralizing UK variant coronavirus with the so-called N501Y mutation of the spike protein, a report by Reuters said.
(To be updated)
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.
Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.